The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens
This study has been completed.
Sponsor:
Stanford University
Collaborators:
Santa Clara Valley Health & Hospital System
University of California, Davis
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00152061
First received: September 8, 2005
Last updated: September 6, 2006
Last verified: September 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | August 2005 |
| Estimated Primary Completion Date: | No date given |